Boundless Bio, Inc.·4

Mar 29, 4:30 PM ET

Wagner Klaus W. 4

4 · Boundless Bio, Inc. · Filed Mar 29, 2024

Insider Transaction Report

Form 4
Period: 2024-03-27
Wagner Klaus W.
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2024-03-27+41,74541,745 total
    Exercise: $16.00Exp: 2034-03-26Common Stock (41,745 underlying)
Footnotes (1)
  • [F1]The stock option vests in 48 substantially equal monthly installments beginning on April 27, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4